Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2024 RedETS working plan published in Spain

On May 23, 2024, the 2024 working plan was published by the Spanish Network of HTA Agencies (RedETS). Topics in cardiovascular, diagnostic imaging, e-health, endoscopy, ENT, extracorporeal treatments, ICU/OR, in-vitro diagnostics, interventional radiology, men’s health, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, orthopedics, peripheral vascular, pulmonary and airways, radiology, radiotherapy, robotic surgery, spine, surgical procedures, and some other fields are included in the plan.

Some examples of the technologies considered for evaluation are provided below:

  • Percutaneous systems for tricuspid valve repair by ISCIII (Health Institute Carlos III);
  • Planning of surgery with the use of three-dimensional printed models in oncological and highly complex surgery by AQuAS (Agency for Health Quality and Assessment of Catalonia);
  • Effectiveness, safety, and cost-effectiveness of prostate cancer screening: update by OSTEBA (Basque Office for Health Technology Assessment);
  • Combined use of electromagnetic navigation with cone beam computed tomography for diagnostics and treatment of pulmonary nodules by AETSA (Andalusian Health Technology Assessment Department);
  • Early detection of graft damage in solid organ recipient patients (Allo-Seq cfDNA/Next Generation Sequencing) by AVALIA-T (Galician Agency for Health Technology Assessment);
  • Monitoring study: High-intensity focused ultrasound (HIFU) in the treatment of movement disorders by SESCS/AQuAS (Health Technology Assessment Unit at the Canary Islands/Agency for Health Quality and Assessment of Catalonia);
  • Sentinel lymph node biopsy in endometrial cancer: part 2 by UETS-Madrid (Health Technology Assessment Unit of the Community of Madrid).

See the full details in Spanish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.